Kamil Hakan Müftüoğlu

3PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 19, 2024
NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma.

Osman Türkmen, Kamil Hakan Müftüoğlu, Nazmiye Dinçer

|Sep 07, 2023
The oncologic outcomes of endometrial cancer metastasizing to the adrenal gland and kidney: from case to analysis.

Okan Aytekin, Fatih Kılıç, Burak Ersak

|May 13, 2020
What is the impact of PPAR-γ agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study

Burcu Gündoğdu, Ömer Lütfi Tapisiz, Berna Dilbaz

Pageof 1